Skip to main content
Livermore
Livermore
ZHEN

Eads & Heald Wealth Management

SEC CIK
0001035912
Latest filing
Jul 31, 2026

LRCX holding history

Lam Research Corp in every 13F filed by Eads & Heald Wealth Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LRCX overviewAll 13F holders of LRCXFull Q2 2026 holdings

Shares (Q2 2026)
14,345
Value
$6.22M
% of portfolio
3.0%
Quarters held
22
Since Q1 2021
Holdings of LRCX by Eads & Heald Wealth Management, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202614,345$6.22M3.0%−4,592−24.2%ReducedHolders
Q1 202618,937$4.05M2.0%−4,051−17.6%ReducedHolders
Q4 202522,988$3.94M1.9%−1,390−5.7%ReducedHolders
Q3 202524,378$3.26M1.6%+250+1.0%AddedHolders
Q2 202524,128$2.35M1.2%+814+3.5%AddedHolders
Q1 202523,314$1.70M0.9%+1,907+8.9%AddedHolders
Q4 202421,407$1.55M0.8%−793−3.6%ReducedConverted for a 10-for-1 splitHolders
Q3 20242,220$1.81M0.9%−81−3.5%ReducedHolders
Q2 20242,301$2.45M1.2%+220+10.6%AddedHolders
Q1 20242,081$2.02M0.9%−81−3.7%ReducedHolders
Q4 20232,162$1.69M0.8%+83+4.0%AddedHolders
Q3 20232,079$1.30M0.7%+257+14.1%AddedHolders
Q2 20231,822$1.17M0.6%−79−4.2%ReducedHolders
Q1 20231,901$1.01M0.5%−89−4.5%ReducedHolders
Q4 20221,990$836.0K0.4%−570−22.3%ReducedHolders
Q3 20222,560$937.0K0.5%−10−0.4%ReducedHolders
Q2 20222,570$1.09M0.6%+44+1.7%AddedHolders
Q1 20222,526$1.36M0.6%+471+22.9%AddedHolders
Q4 20212,055$1.48M0.6%+11+0.5%AddedHolders
Q3 20212,044$1.16M0.6%−35−1.7%ReducedHolders
Q2 20212,079$1.35M0.7%+209+11.2%AddedHolders
Q1 20211,870$1.11M0.6%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.